tranexamic acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "None of the patients experienced further bleeding following the commencement of tranexamic acid treatment, and no adverse effect was noted." | 4.89 | Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review. ( Clark, JR; Elliott, M; Huang, J; Low, TH; Reid, C, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Low, TH | 1 |
| Huang, J | 1 |
| Reid, C | 1 |
| Elliott, M | 1 |
| Clark, JR | 1 |
1 review available for tranexamic acid and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifibrinolytic Agents; Carcinoma, Squamous Cell; Ep | 2013 |